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Summary
Background Worldwide, use of tobacco is viewed as an important threat to the health of pregnant women and their 
children. However, the extent of tobacco use in pregnant women in low-income and middle-income countries 
(LMICs) remains unclear. We assessed the magnitude of tobacco use in pregnant women in LMICs.
Methods We used data from Demographic and Health Surveys (DHS) done in 54 LMICs between Jan 1, 2001, and 
Dec 1, 2012, comprising 58 922 pregnant women (aged 15–49 years), which were grouped by WHO region. Prevalence 
of current tobacco use (smoked and smokeless) was estimated for every country. Pooled estimates by regions and 
overall were obtained from random-eﬀ ects meta-analysis.
Findings Pooled prevalence of any tobacco use in pregnant women in LMICs was 2·6% (95% CI 1·8–3·6); the lowest 
prevalence was in the African region (2·0%, 1·2–2·9) and the highest was in the Southeast Asian region (5·1%, 
1·3–10·9). The pooled prevalence of current tobacco smoking in pregnant women ranged from 0·6% (0·3–0·8) in 
the African region to 3·5% (1·5–12·1) in the Western Paciﬁ c region. The pooled prevalence of current smokeless 
tobacco use in pregnant women was lowest in the European region (0·1%, 0·0–0·3) and highest in the Southeast 
Asian region (2·6%, 0·0–7·6).
Interpretation Overall, tobacco use in pregnant women in LMICs was low; however high prevalence estimates were 
noted in some LMICs. Prevention and management of tobacco use and exposure to second-hand smoke in pregnancy 
is crucial to protect maternal and child health in LMICs.
Funding None.
Copyright © Caleyachetty et al. Open Access article distributed under the terms of CC BY.
Introduction
Tobacco is a leading global disease risk factor.1 Although 
more than 80% of the world’s smokers live in low-income 
and middle-income countries (LMICs),2 population-based 
data for prevalence of tobacco use in pregnant women in 
these countries is insuﬃ  cient. The 2008–10 Global Adult 
Tobacco Survey of 14 LMICs showed that in women of 
reproductive age, prevalence of current tobacco smoking 
ranged from 0·4% in Egypt to 30·8% in Russia, and 
current smokeless tobacco use was less than 1% in most 
countries, but was common in Bangladesh (20%) and 
India (15%).3
The risks associated with tobacco smoking during 
pregnancy for both mother and child have been 
established,4 and include pregnancy complications (ie, 
placenta praevia, placental abruption, and pre-eclampsia) 
and poor fetal outcomes (ie, low birthweight, premature 
birth, and overall perinatal mortality).5,6 The use of several 
forms of smokeless tobacco (eg, snuﬀ  or chewing 
tobacco) during pregnancy is less studied but has also 
been associated with stillbirth, preterm birth, and 
reduced birthweight.7
Identiﬁ cation of where smoking cessation interventions 
for pregnant women are most needed in LMICs is 
particularly important in view of the insuﬃ  cient antenatal 
care capacities and poor pregnancy outcomes in many 
LMICs.8 However, there are no population-based estimates 
of tobacco use during pregnancy in LMICs.
We aimed to estimate the prevalence of current tobacco 
use in pregnant women in LMICs using data from 
54 nationally representative household surveys, and 
investigate potential sources of heterogeneity in the 
estimates across countries and geographic regions.
Methods
Data sources and procedures
We searched for data from the most recent Demographic 
and Health Survey (DHS) in every country, which were 
done between Jan 1, 2000, and Jan 1, 2014, with data 
available for pregnancy status and tobacco use. The DHS 
are nationally representative cross-sectional house hold 
surveys done at about 5-year intervals across LMICs. 
DHS are designed to collect data on health and welfare 
from women of reproductive age, their children, and their 
households. In all countries, these surveys followed the 
same standardised procedures. Complete descriptions of 
country DHS sampling, questionnaire validation, data 
collection methods, and data validation procedures are 
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Pregnant
(n)
Response
rate*
Age (years) Urban 
dwellers (%)
Lowest house-
hold wealth 
quintile (%)
Not working 
(%)
No education 
(%)
Albania, 2008–09 136 100·0% 26·3 39·2% 16·4% 80·9% 0·7%
Armenia, 2010 174 99·4% 24·5 64·0% 16·9% 81·9% 0·0%
Benin, 2006 1946 100·0% 26·9 33·8% 21·3% 17·3% 74·6%
Bolivia, 2008 926 99·8% 26·8 58·3% 23·4% 35·7% 4·2%
Burkina Faso, 2010 1687 99·8% 27·0 18·0% 18·8% 22·9% 81·9%
Burundi, 2010 928 100·0% 27·8 9·1% 19·8% 9·2% 50·1%
Cambodia, 2010 929 100·0% 25·9 16·0% 23·0% 18·2% 16·5%
Cameroon, 2011 1492 99·8% 26·4 43·7% 22·5% 32·6% 27·5%
Congo (Brazzaville), 2011–12 1114 99·8% 26·6 64·6% 20·1% 32·9% 7·0%
DR Congo, 2007 1100 100·0% 26·3 37·8% 20·0% 24·4% 22·4%
CÔte d’Ivoire, 2011–12 1016 99·8% 26·6 41·7% 21·6% 33·4% 59·3%
Dominican Republic, 2007 1279 99·6% 24·0 67·7% 26·4% 60·3% 3·9%
Egypt, 2005 1869 99·9% 25·4 36·6% 18·4% 86·0% 25·4%
Ethiopia, 2011 1277 99·9% 27·5 12·5% 24·4% 45·0% 61·4%
Gabon, 2012 873 99·3% 26·3 87·4% 18·3% 55·4% 5·4%
Ghana, 2008 365 100·0% 27·8 41·5% 18·8% 17·0% 25·9%
Guinea, 2005 767 100·0% 27·5 23·6% 23·7% 16·6% 85·0%
Guyana, 2009 233 99·1% 25·1 20·6% 28·0% 70·7% 3·9%
Haiti, 2012 872 100·0% 26·6 37·6% 18·7% 41·3% 17·5%
Honduras, 2012 1276 99·9% 24·6 52·3% 21·4% 50·8% 4·2%
India, 2006 5911 99·9% 23·6 24·7% 24·4% 67·4% 46·4%
Indonesia, 2012 2060 99·9% 27·9 50·3% 20·8% 40·1% 1·0%
Jordan, 2012 1132 100·0% 27·6 82·8% 18·2% 87·0% 1·3%
Kenya, 2008 622 99·8% 26·4 24·4% 23·4% 39·6% 12·5%
Kyrgyzstan, 2012 588 99·8% 25·8 33·8% 18·1% 76·7% 0·0%
Lesotho, 2009 336 100·0% 24·5 25·7% 18·0% NA 1·2%
Liberia, 2007 741 100·0% 27·3 30·5% 24·8% 29·3% 47·1%
Madagascar, 2008–09 1449 99·9% 25·3 11·2% 24·6% 10·3% 23·4%
Malawi, 2010 2162 99·9% 26·0 12·1% 19·9% 28·3% 14·7%
Maldives, 2009 558 100·0% 26·8 26·4% 18·7% 53·8% 8·3%
Mali, 2006 1795 99·7% 26·7 26·4% 20·7% 57·0% 85·0%
Moldova, 2005 179 100·0% 25·4 40·6% 15·0% 55·1% 0·0%
Mozambique, 2011 1409 100·0% 26·0 25·8% 25·6% 56·7% 35·5%
Namibia, 2006–07 579 100·0% 27·1 41·7% 21·3% 48·2% 8·9%
Nepal, 2011 614 100·0% 23·6 11·8% 20·9% 34·6% 36·9%
Nicaragua, 2001 667 100·0% 24·3 53·1% NA 64·6% 19·1%
Niger, 2006 1210 99·8% 27·0 13·6% 17·7% 52·7% 86·0%
Nigeria, 2008 3547 99·7% 27·1 30·9% 23·6% 34·4% 43·0%
Pakistan, 2012–13 1495 99·9% 26·7 26·9% 24·9% 73·4% 54·7%
Peru, 2007–08 1860 86·2% 27·4 60·2% 15·0% 25·3% 3·2%
Philippines, 2008 729 100·0% 27·2 46·3% 26·5% 50·9% 1·4%
Rwanda, 2010 937 99·9% 27·7 15·7% 20·7% 12·0% 16·4%
São Tomé and Príncipe, 2008–09 225 100·0% 26·2 53·2% 20·1% 53·9% 5·2%
Senegal, 2010–11 1297 100·0% 27·1 37·9% 26·0% 58·6% 68·6%
Sierra Leone, 2008 571 99·6% 26·0 28·7% 21·1% 20·1% 72·3%
Swaziland, 2006–07 273 100·0% 24·7 26·6% 20·7% 58·7% 7·9%
Tajikistan, 2012 700 99·9% 24·6 20·6% 16·5% 73·9% 2·1%
Tanzania, 2010 945 100·0% 26·1 18·9% 18·5% 15·1% 25·5%
Timor Leste, 2009–10 902 100·0% 28·2 27·4% 17·8% 67·3% 28·9%
Turkey, 2003 524 99·6% 25·6 63·4% 24·1% NA 17·7%
Uganda, 2011 963 99·8% 26·3 13·9% 22·8% 23·7% 13·2%
(Table 1 continues on next page)
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published elsewhere.9 Brieﬂ y, the DHS use a stratiﬁ ed 
two-stage random sampling approach, consisting of 
a selection of census enumeration areas based on a 
probability (proportional to area size), followed by a 
random selection of households from a complete listing 
of households within the selected enumeration areas. For 
every sampled household, one member answers general 
questions about the household and provides a list of 
household residents. Then, all consenting women aged 
15–49 years in the household are interviewed. The 
response rates for pregnant women for the available 
eligible DHS ranged from 86·2% to 100·0% (mean 
99·6%, SD 1·9; table 1). The DHS was approved centrally 
by ICF International (Calverton, MD, USA) institutional 
review board and by individual review boards within 
every participating country.
Outcomes
The current pregnancy status of women was self-reported 
and ascertained from the question, “Are you pregnant 
now?”, with the response options “yes” or “no or unsure”.
In the DHS, tobacco use is ascertained by questionnaire. 
Participants were asked four questions to be answered by 
“yes” or “no” about whether, at current, they use cigarettes, 
pipes, or other country-speciﬁ c tobacco smoking products 
or nothing. The DHS contains no information about age at 
initiation, former smoking status, or age at cessation. 
Pregnant women were classiﬁ ed as a “tobacco smoker” if 
the response was “yes” to smoking cigarettes, pipes, or 
other country-speciﬁ c smoking products. Pregnant 
women were classiﬁ ed as “smokeless tobacco users” if the 
response was “yes” to the use of chew, snuﬀ , or other 
country-speciﬁ c smokeless tobacco products. Pregnant 
women who smoke tobacco or use smokeless tobacco 
were classiﬁ ed as “any tobacco users”.
The participants’ place of residence was categorised as 
rural versus urban. Maternal education was assessed by 
self-report of the completed educational level (no 
education, primary, secondary, or higher). Maternal 
occupation was measured through the question, “What is 
your primary occupation, or class of work?” Responses 
were organised under three categories: professional, 
technical, or service; agriculture or manual; and not 
working, and responses were categorised as not working, 
Pregnant
(n)
Response
rate*
Mean age 
(years)
Urban 
dwellers (%)
Lowest 
household 
wealth quintile 
(%)
Not working 
(%)
No education 
(%)
(Continued from previous page)
Ukraine, 2007 190 99·5% 26·2 76·7% 12·1% 29·8% 0·0%
Zambia, 2007 770 100·0% 26·6 30·6% 22·0% 48·8% 10·5%
Zimbabwe, 2010–11 723 100·0% 26·1 34·0% 20·2% 61·5% 1·7%
Means and percentages for variables are calculated with appropriate sampling weight. *The response rate for pregnant women who completed the Demographic and Heath 
Surveys questions on tobacco use. NA=not measured in survey. 
Table 1: Characteristics of pregnant women in the Demographic Health Surveys across countries by year of survey
Prevalence of tobacco 
smoking (95% CI)
Prevalence of smokeless 
tobacco use (95% CI)
Prevalence of any 
tobacco use (95% CI)
Eastern Mediterranean
Egypt, 2005 0·4% (0·1–0·9) 0·1% (0·0–0·5) 0·4% (0·2–1·0)
Jordan, 2012 9·6% (6·8–13·4) ND 9·6% (6·8–13·4)
Pakistan, 2012–13 3·8% (2·6–5·5) 1·9% (1·0–3·5) 5·4% (3·9–7·5)
Pooled region estimate 2·6% (0·7–9·5) 0·6% (0·0–2·5) 3·1% (0·9–10·0)
Statistical heterogeneity, I² 99·0 (98·4–99·4) 96·9 (91·7–98·8) 99·1 (98·6–99·4)
Europe
Albania, 2008–09 3·2% (1·0–9·2) ND 3·2% (1·0–9·2)
Armenia, 2010 0·3% (0·04–2·2) 0·0% 0·3% (0·04–2·2)
Kyrgyzstan, 2012 0·8% (0·3–2·4) 0·3% (0·0–1·8) 0·8% (0·3–2·4)
Moldova, 2005 0·8% (0·2–3·3) 0·0% 0·8% (0·2–3·3)
Tajikistan, 2012 0·1% (0·0–0·8) 0·0% 0·1% (0·0–0·8)
Turkey, 2003 15·0% (11·8–18·9) ND 15·0% (11·8–18·9)
Ukraine, 2007 3·9% (1·4–10·8) 0·0% 3·9% (1·4–10·8)
Pooled region estimate 2·5% (0·0–6·4) 0·1% (0·0–0·3) 2·5% (0·0–6·4)
Statistical heterogeneity, I² 96·5 (94·6–97·7) 0·0 (0·0–33·2) 96·5 (94·6–97·7)
African
Benin, 2006 0·0% (0·0–0·3) ND 0·0% (0·0–0·3)
Burkina Faso, 2010 0·0% 2·8% (2·0–3·8) 2·8% (2·0–3·8)
Burundi, 2010 0·2% (0·1–0·7) 3·7% (2·4–5·6) 8·2% (6·3–10·5)
Cameroon, 2011 0·2% (0·0–1·1) 0·1% (0·0–0·4) 0·2% (0·1–0·6)
Congo (Brazzaville), 2011–12 0·5% (0·2–1·3) 0·8% (0·4–1·5) 1·3% (0·7–2·2)
DR Congo, 2007 0·1% (0·0–0·4) 1·3% (0·6–2·7) 1·4% (0·7–2·8)
CÔte d’Ivoire, 2011–12 0·5% (0·1–2·2) 1·0% (0·5–2·0) 1·5% (0·8–3·0)
Ethiopia, 2011 0·8% (0·4–1·9) 0·2% (0·0–0·9) 1·0% (0·5–2·1)
Gabon, 2012 2·3% (0·2–5·0) 0·2% (0·1–0·5) 2·4% (0·1–5·0)
Ghana, 2008 0·3% (0·0–2·1) 0·2% (0·0–1·6) 0·5% (0·1–2·1)
Guinea, 2005 1·4% (0·6–3·4) ND 2·0% (1·0–4·1)
Kenya, 2008 0·3% (0·1–1·1) 2·6% (0·9–5·6) 2·4% (1·0–5·7)
Lesotho, 2009 0·0% 5·1% (3·2–8·0) 5·1% (3·2–8·0)
Liberia, 2007 1·6% (0·8–3·2) 2·0% (0·9–4·3) 5·1% (3·2–8·0)
Madagascar, 2008–09 0·4% (0·2–0·9) 11·8% (9·6–14·3) 11·9% (9·8–14·4)
Malawi, 2010 0·2% (0·0–0·9) 0·4% (0·2–1·0) 0·6% (0·3–1·3)
Mali, 2006 0·0 (0·0–0·3) ND 0·0 (0·0–0·3)
Mozambique, 2011 0·8% (0·4–1·6) 0·4% (0·2–1·1) 0·8% (0·4–1·6)
Namibia, 2006–07 5·4% (3·4–8·6) 2·2% (1·2–4·0) 7·6% (5·3–11·0)
Niger, 2006 0·0% ND 0·0% 
Nigeria, 2008 0·1% (0·0–0·3) 0·5% (0·2–0·9) 0·6% (0·3–1·0)
Rwanda, 2010 0·3% (0·1–0·9) 2·0% (1·2–3·2) 2·2% (1·4–3·5)
(Table 2 continues on next page)
For more on the Macro 
International. Demographic 
and Health Surveys (DHS) see 
http://www.measuredhs.com
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non-manual, manual, and agricultural. Household wealth 
was measured as a composite measure of household 
assets (eg, bicycles, cars, or radios) and characteristics 
(eg, ﬂ ooring material, drinking water source, or type of 
toilet facility). Household wealth was further divided into 
ﬁ ve quintiles (poorest, poor, middle, rich, or richest).
Statistical analysis
The DHS used complex sample designs that involved 
clustering of households. We therefore calculated 
sampling weights to account for diﬀ erential probabilities 
of selection and participation, and estimated proportions 
and 95% CIs for current tobacco smoking, smokeless 
tobacco use, and any tobacco use in pregnant women 
from every country, accounting for stratiﬁ cation and 
clustering in the sample design. Pooled regional estimates 
were computed by ﬁ rst stabilisation of the variances of 
the raw proportions with a double arc-sine transformation 
and then application of a DerSimonian-Laird 
random-eﬀ ects model. Heterogeneity between 
study-speciﬁ c estimates was assessed with the I² statistic; 
values of 25% or less indicated low heterogeneity, values 
near 50% corresponded to moderate heterogeneity, and 
values near 75% or greater indicated high heterogeneity. 
We further explored potential sources of heterogeneity 
for any tobacco use through meta-regression analysis. We 
did univariable analyses to test the individual association 
of several a priori country-level covariates with pooled 
estimates: year of survey (≤2009 vs >2009, for which 2009 
is the median year of the 11-year period covered by the 
various country-speciﬁ c DHS surveys), percentage of 
people living in urban areas (below median value vs at 
and above median value), or gross national income based 
on purchasing power parity (below median value vs at and 
above median value). No more than one covariate was 
signiﬁ cantly associated with the outcome in region-
speciﬁ c univariable meta-regression models. Accordingly, 
we therefore did not develop multiple meta-regression 
models. The p value was obtained from random-eﬀ ects 
meta-regression. Weighted proportions and 95% CIs 
were calculated with STATA version 11·2 (Stata, College 
Station, TX, USA). Meta-XL version 1·3 was applied to 
stabilise the variances of the raw proportions and pool 
proportions with a random-eﬀ ects model.
Role of the funding source
There was no funding source for this study. RC had 
access to the full data set and ﬁ nal responsibility to 
submit the report.
Results
54 countries with valid DHS data were included in our 
analyses. By WHO region per total number of LMICs, 
seven (35%) of 20 countries in Europe, three (20%) of 
Prevalence of tobacco 
smoking (95% CI)
Prevalence of smokeless 
tobacco use (95% CI)
Prevalence of any 
tobacco use (95% CI)
(Continued from previous page)
São Tomé and Príncipe, 
2008–09
0·2% (0·0–1·0) 0·2% (0·0–1·4) 0·4% (0·1–1·3)
Senegal, 2010–11 0·2% (0·0–0·8) 0·3% (0·1–0·8) 0·5% (0·2–1·1)
Sierra Leone, 2008 4·5% (2·9–6·9) 4·6% (3·0–6·9) 8·3% (6·1–11·3)
Swaziland, 2006–07 1·3% (0·5–3·6) 0·6% (0·2–2·4) 2·0% (0·9–4·4)
Tanzania, 2010 0·2% (0·0–0·7) 0·9% (0·4–2·0) 1·1% (0·5–2·1)
Uganda, 2011 0·3% (0·1–0·8) 1·9% (1·2–3·1) 2·2% (1·4–3·3)
Zambia, 2007 0·5% (0·2–1·3) 1·1% (0·6–2·1) 1·4% (0·8–2·5)
Zimbabwe, 2010–11 0·0% 0·4% (0·1–1·4) 0·4% (0·1–1·4)
Pooled region estimate 0·6% (0·3–0·8) 1·7% (1·0–2·6) 2·0% (1·2–2·9)
Statistical heterogeneity, I² 89·6 (86·5–92·2) 96·2 (95·3–97·0) 96·9 (96·3–97·4)
Americas
Bolivia, 2008 4·1% (2·6–6·4) ND 4·1% (2·6–6·4)
Dominican Republic, 2007 2·4% (1·4–4·1) 0·1% (0·0–0·4) 2·7% (1·7–4·4)
Guyana, 2009 3·5% (1·3–9·1) 0·0% 3·5% (1·3–9·1)
Haiti, 2012 1·0% (0·5–2·2) 2·7% (1·6–4·7) 3·6% (2·3–5·7)
Honduras, 2012 0·7% (0·3–1·8) 0·0% 0·7% (0·3–1·8)
Nicaragua, 2001 1·3% (0·5–3·3) 0·0% 1·3% (0·5–3·3)
Peru, 2007–08 1·3% (0·7–2·2) ND 1·3% (0·7–2·2)
Pooled region estimate 1·8% (1·1–2·6) 0·3% (0·0–1·1) 2·1% (1·2–3·2)
Statistical heterogeneity, I² 82·8 (65·8–91·3) 91·4 (82·9–95·7) 90·0 (81·9–94·4)
Southeast Asia
India, 2006 1·0% (0·7–1·5) 7·2% (6·3–8·1) 8·0% (7·1–9·0)
Indonesia, 2012 0·7% (0·4–1·4) 0·3% (0·1–0·7) 1·0% (0·6–1·7)
Maldives, 2009 1·8% (0·9–3·4) 1·6% (0·7–3·5) 3·3% (2·0–5·5)
Nepal, 2011 5·9% (4·1–8·4) 2·8% (1·6–4·9) 8·4% (6·0–11·5)
Timor Leste, 2009–10 3·4% (2·3–4·8) 1·2% (0·6–2·1) 3·7% (2·6–5·2)
Pooled region estimate 2·7% (1·1–4·8) 2·6% (0·0–7·6) 5·1% (1·3–10·9)
Statistical heterogeneity, I² 95·9 (92·9–97·7) 99·2 (99·0–99·5) 98·8 (98·3–99·2)
Western Paciﬁ c
Cambodia, 2010 3·4% (1·8–6·4) 3·5% (2·4–5·2) 6·7% (4·6–9·7)
Philippines, 2008 2·4% (1·5–3·9) 0·1% (0·0–0·4) 2·5% (1·6–3·9)
Pooled region estimate 3·5% (1·5–12·1) 1·6% (0·0–7·1) 4·5% (0·3–12·1)
Statistical heterogeneity, I² 84·7 (37·4–96·2) 97·8 (94·6–99·0) 96·7 (91·2–98·8)
Overall
Overall pooled estimate 1·3 (0·9–1·8) 1·3 (0·7–2·0) 2·6 (1·8–3·6)
ND=no data collected.
Table 2: Prevalence of tobacco use in pregnant women by WHO region
Figure 1: Pooled prevalence of current smoking in pregnant women by 
WHO region
Black squares are the eﬀ ect estimates (pooled prevalence) and the horizontal 
bars show 95% CIs. Pooled estimates were derived from double arc-sine 
transformed prevalence and back-transformed for reporting.
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15 in the Eastern Mediterranean, 30 (65%) of 46 in Africa, 
seven of (27%) 26 in the Americas, ﬁ ve (45%) of 11 in 
Southeast Asia, and two (11%) of 18 in the Western Paciﬁ c 
had DHS data. Table 1 shows the country-level 
characteristics of participants. The mean age of pregnant 
women ranged from 23·6 to 28·2 years. The proportion 
of pregnant women who had no formal education ranged 
from 0·0% (Armenia, Kyrgyzstan, Moldova, Ukraine) to 
86·0% (Niger), and 23 (42·6%) of 54 surveys had more 
than 20% of pregnant women with no formal education. 
The proportion of households classiﬁ ed in the lowest 
household wealth quintile ranged from 12·1% (Ukraine) 
to 28·0% (Guyana), whereas the proportion of pregnant 
women who were not in work ranged from 9·2% 
(Burundi) to 87·0% (Jordan).
1·3% (95% CI 0·9–1·8) of pregnant women from 
LMICs reported smoking tobacco (table 2). The prevalence 
of current tobacco smoking varied substantially across 
countries, ranging from 0·0% (in Benin, Burkina Faso, 
Lesotho, Mali, Niger, and Zimbabwe) to 15·0% (in 
Turkey). Figure 1 shows the pooled prevalence of current 
tobacco smoking in pregnant women by WHO region. 
The pooled regional prevalence of current tobacco 
smoking ranged from 0·6% (95% CI 0·3–0·8) in the 
African region to 3·5% (1·5–12·1) in the Western Paciﬁ c 
region. The percentage of countries with a prevalence 
above the overall pooled estimate for tobacco smoking in 
pregnant women was 100% (two of two) in the West 
Paciﬁ c region, 60% (three of ﬁ ve) in the Southeast Asia 
region, 67% (two of three) in the Eastern Mediterranean 
region, 43% (three of seven) in the Americas region, 43% 
(three of seven) in European region, and 17% (ﬁ ve of 30) 
in the African region.
45 countries had data for use of smokeless tobacco in 
pregnant women. 1·3% (95% CI 0·7–2·0) of pregnant 
women from LMICs reported use of smokeless tobacco 
(table 2). We noted substantial variation in the prevalence 
of current smokeless tobacco use from 0·0% (in 
Armenia, Moldova, Tajikistan, Ukraine, Guyana, 
Honduras, and Nicaragua) to 11·8% (in Madagascar). 
Figure 2 shows the pooled prevalence of current 
smokeless tobacco use in pregnant women by WHO 
region. The pooled regional prevalence of current 
smokeless tobacco use in pregnant women was lowest in 
Europe (0·1%, 95% CI 0·0–0·3) and highest in Southeast 
Asia (2·6%, 0·0–7·6). The proportion of countries with a 
prevalence greater than the overall pooled estimate for 
smokeless tobacco use in pregnant women was 60% 
(three of ﬁ ve) in the Southeast Asian region, 50% (one of 
two) in the West Paciﬁ c region, 38% (10 of 26) in the 
African region, 50% (one of two) in the Eastern 
Mediterranean region, and 20% (one of ﬁ ve) in the 
Americas region. No country in the Europe region had a 
prevalence greater than the overall pooled estimate for 
smokeless tobacco use in pregnant women. 
2·6% (95% CI 1·8–3·6) of pregnant women from 
LMICs reported any tobacco use (table 2). The prevalence 
of any current tobacco use in pregnant women ranged 
from 0·0% (Benin, Mali, Niger) to 15·0% (Turkey). 
Figure 3 shows the pooled prevalence of any tobacco use 
in pregnant women by WHO region. The pooled 
prevalence of any tobacco use in pregnant women was 
lowest in the African region (2·0%, 95% CI 1·2–2·9) and 
highest in Southeast Asia (5·1%, 1·3–10·9). The 
proportion of countries with a prevalence above the 
overall pooled estimate for any tobacco use in pregnant 
women was 80% (four of ﬁ ve) in the Southeast Asian 
region, 67% (two of three) in the Eastern Mediterranean 
region, 57% (four of seven) in the Americas region, 50% 
(one of two) in the West Paciﬁ c region, 43% (three of 
seven) in the European region, and 23% (seven of 30) in 
the African region.
Table 2 shows substantial heterogeneity in prevalence 
estimates of tobacco use between countries in every 
region and across regions.
In univariable meta-regression analysis, we noted a 
higher prevalence of any tobacco use in pregnant women 
for countries with surveys done after 2009 in the 
Eastern Mediterranean region (p=0·019) and in countries 
with a higher proportion of people living in urban areas 
in the Americas region (p=0·012 table 3). We also noted a 
lower prevalence of any tobacco use in pregnant women 
for countries with a higher gross national income per 
head in the Southeast Asian region (table 3).
Figure 2: Pooled prevalence of current smokeless tobacco use by pregnant 
women by WHO region
Black squares are the eﬀ ect estimates (pooled prevalence) and the horizontal 
bars show 95% CIs. Pooled estimates were derived from double arc-sine 
transformed prevalence, and back-transformed for reporting.
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Discussion
To our knowledge, this study is the largest to provide 
contemporary evidence on tobacco use during pregnancy 
using nationally representative samples from 54 LMICs. 
During 2001–12, about one in every 30 pregnant women 
used tobacco, with wide variations in prevalence within 
and between world regions (panel). The highest regional 
prevalence of any tobacco use was in the Southeast Asian 
region and the lowest was in the African region. 
Additionally, we noted that in 21 countries, smokeless 
tobacco was the primary form of tobacco use in pregnant 
women, thus showing the need to account for these forms 
of tobacco use in prevention programmes. Both smoked 
and smokeless forms of tobacco encompass a very diverse 
group of products.10 Smokeless tobacco is often less 
expensive than manufactured cigarettes and is sometimes 
viewed by pregnant women as a form of medicine to treat 
inﬂ uenza, colds, and other common ailments,11 as a safer 
alternative to tobacco smoking,12 or in some countries is 
more socially acceptable than tobacco smoking in women.7
Although the prevalence of tobacco use by women 
during pregnancy is low at current, evidence suggests that 
it might rise during the coming decades.13 Data from the 
Global Youth Tobacco Survey 2006 showed that the 
diﬀ erence in current cigarette smoking between boys and 
girls is narrower than expected in many regions of the 
world, suggesting substantial future increases in tobacco 
use.13 Moreover, as long as tobacco use remains much 
lower in women than in men, women will constitute an 
obvious target for multinational tobacco companies.
Bhatti and colleagues14 previously reported that the 
prevalence of tobacco use in pregnant women in LMICs 
ranged between 0·1% and 11·9%; however, these data 
were estimated from selected DHS data (42 countries). 
Our study is more comprehensive because it includes all 
available DHS data, and we show that the prevalence of 
tobacco use in pregnant women ranges from 0% to 15%. 
Other studies on the prevalence of tobacco use in pregnant 
women in LMICs15–21 have typically used convenience 
samples22 or have been hospital-based studies limited to 
certain regions,15,16,18,19,21 and thus are more prone to selection 
bias. For example, in a multicentre, cross-sectional survey17 
with a convenience sample of pregnant women from 
several LMICs (at the time of survey), including those 
from Latin America (Argentina, Brazil, Ecuador, 
Guatemala, and Uruguay), Africa (DR Congo and Zambia), 
and Asia (Pakistan and two states in India), the prevalence 
of current tobacco smoking was 18·3% in Uruguay, 10·3% 
in Argentina, 6·1% in Brazil, 6·4% in Guatemala, and 
3·0% in Pakistan; prevalences were not calculated at all 
other sites because there were fewer than ﬁ ve current 
smokers. The prevalence of ever having used non-cigarette 
tobacco products in all other countries surveyed was less 
than 5%. Much higher prevalence estimates of tobacco 
smoking in pregnant women have been reported from 
population-based studies in high-income countries, 
including the USA (12·3%)23 and the UK (36·0%).24
The DHS data we present could be the basis for 
surveillance of tobacco use in pregnant women in 
LMICs, and might be the best available surveillance data 
in countries where there are no existing surveillance 
systems or regular surveys that collect tobacco use 
information in pregnant women. Reliance of LMICs on 
the DHS programme to obtain surveillance data for 
tobacco use in pregnant women is restricted, in that the 
surveys are initiated by the United States Agency for 
International Development (USAID) and do not cover 
countries where the USAID is not established.
We detected a high level of heterogeneity in prevalence 
of any tobacco use across countries and regions. 
Eastern Mediterranean Europe Africa Americas Southeast Asia Western Paciﬁ c
N* Prevalence
(95% CI)
p value N* Prevalence
(95% CI)
p value N* Prevalence
(95% CI)
p value N* Prevalence
(95% CI)
p value N* Prevalence
(95% CI)
p value N* Prevalence
(95% CI)
p value
Year
≤2009 1 0·4%
(0·2–1·0)
4 4·1%
(0·0–12·0)
16 2·1%
(0·8–4·0)
5 2·3%
(1·4–3·3)
3 5·5%
(1·5–11·6)
1 2·5%
(1·6–3·9)
>2009 2 8·8%
(7·6–10·5)
0·019 3 0·4%
(0·1–0·8)
0·085 14 1·7%
(0·9–2·7)
0·635 2 1·8%
(0·0–5·3)
0·671 2 5·0%
(0·0–16·3)
0·846 1 6·7%
(4·6–9·7)
NA
People living in urban areas
Below 
median
1 5·4%
(3·9–7·5)
3 5·1%
(0·0–15·2)
14 2·5%
(1·1–4·4)
2 1·8%
(0·3–5·1)
2 6·4%
(1·4–14·1)
1 6·7%
(4·6–9·7)
Above 
median
2 3·4%
(0·0–10·3)
0·647 4 0·8%
(0·1–1·9)
0·136 16 1·5%
(0·8–2·5)
0·233 5 2·3%
(1·5–3·4)
0·012 3 4·7%
(0·0–12·7)
0·636 1 2·5%
(1·6–3·9)
NA
Gross national income per head based on purchasing power parity (current international $)
Below 
median
1 9·6%
(6·8–13·4)
3 0·4%
(0·1–1·1)
14 2·3%
(0·9–4·4)
3 2·3%
(0·6–4·8)
2 11·0%
(10·3–11·8)
1 6·7%
(4·6–9·7)
Above 
median
2 3·6%
(0·0–14·6)
0·647 4 3·7%
(0·0–12·0)
0·136 15 1·7%
(0·9–2·6)
0·341 4 1·9%
(0·9–3·3)
0·640 3 2·8%
(1·1–5·2)
0·019 1 2·5%
(1·6–3·9)
NA
*Number of countries. NA=not applicable, p value not calculated because of small number of countries. 
Table 3: Pooled prevalence of any tobacco use in pregnant women by WHO region and by subgroups
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However, few covariates suﬃ  ciently explained the 
heterogeneity, suggesting that the source of variation lies 
elsewhere. Sociocultural histories of tobacco use, the 
local economy of tobacco including marketing, and 
possibly the extent of the implementation of the WHO 
Framework Convention on Tobacco Control (FCTC) 
Articles might be more important to explain national 
diﬀ erences within the LMICs. Understanding the 
sources of heterogeneity will be crucial to predict future 
trends and target strategies of control, particularly in 
countries already facing worrying rates of tobacco use.
Our study has some limitations that need to be 
considered. First, tobacco smoking status was 
self-reported; hence, misclassiﬁ cation of smoking status 
is possible.25 Evidence from high-income countries 
suggests that up to a quarter of pregnant tobacco 
smokers could be missed when self-reporting is relied 
upon.25,26 Although under-reporting of smoking status 
by pregnant women is unknown in LMICs, smoking 
status could be much higher in LMICs with strong 
social and cultural pressures against tobacco smoking 
in women. Future studies could overcome this limitation 
by use of biomarkers of tobacco exposure such as 
urinary cotinine, at least in a subsample of their 
population for validation of self-report. Second, in the 
DHS, pregnancy status was ascertained by self-report. 
Misclassiﬁ cation of pregnant women as non-pregnant 
will potentially have an eﬀ ect on our estimates if this 
occurred in a diﬀ erent way between tobacco users and 
non-users. Such a hypothesis is diﬃ  cult to ascertain, 
but is unlikely in the context of multicountry surveys. 
Third, the study was constrained by the scarce 
availability of country data from every WHO region. 
Fourth, country-speciﬁ c prevalence of tobacco use 
reﬂ ected estimates during an 11-year period. Given that 
prevalence of tobacco smoking in females in LMICs 
could be growing,27 the prevalence estimates of tobacco 
use in our study might be smaller than those in 
contemporary studies. However, we only showed that 
prevalence estimates for any tobacco use in pregnant 
women for countries with surveys done after 2009 in the 
Eastern Mediterranean region were signiﬁ cantly higher 
than those before 2009. Finally, our study did not 
include other ways in which tobacco use might harm 
pregnant women and children. For example, second-
hand smoke exposure has been reported to be highly 
prevalent in women of reproductive age in some 
LMICs,28 including during pregnancy.17 Additionally, 
tobacco use by family members might divert 
household income from food to tobacco, putting infants 
at increased risk of chronic malnutrition and mortality.29
Maternal and fetal complications related to tobacco 
use in pregnant women are numerous,5,6 and possibly 
also include obesity and obesity-related metabolic 
compli cations.30 Because maternal and child health 
outcomes are often poor in many LMICs,8 use of tobacco 
by pregnant women in these settings could substantially 
worsen outcomes, and therefore slow progress to 
achieve the Millennium Development Goals 4 (Reduce 
Child Mortality) and 5 (Improve Maternal Health).22 The 
main recommendations of the WHO FCTC on the 
prevention and management of tobacco use and 
exposure to second-hand smoke in pregnancy31 include 
screening for tobacco use and second-hand smoke 
exposure, advice and psychosocial interventions for 
tobacco cessation to those who are current tobacco 
users, and protection from second-hand smoke. 
Although many LMICs have ratiﬁ ed the FCTC, the 
implementation of the provisions are still a challenge.32 
For example, although most African countries require 
tobacco health warning messages (WHO FCTC Article 
11), at current only three countries (Mauritius, Djibouti, 
and Madagascar) require picture-based warnings. 
Furthermore, a few studies in LMICs have incorporated 
cigarette smoking cessation interventions (WHO FCTC 
Article 14) into existing health-care services for pregnant 
women.33,34 However, no interventions on other forms of 
smoked or smokeless tobacco have been tested;29 hence 
the importance of our study in showing the magnitude 
of the use of smokeless tobacco in speciﬁ c countries. 
These data could aid in the cultural adaptation of 
tobacco control interventions to make these more 
acceptable and feasible, and integrated into existing 
health-care delivery systems.
Tobacco use in pregnant women in low-income and 
middle-income countries was low; however, in Turkey it 
reached levels as high as 15%. The expansion of the 
tobacco industry’s marketing eﬀ orts to women of 
reproductive age in low-income and middle-income 
countries suggests that the prevalence of tobacco use 
might increase if the WHO FCTC Articles are not 
Panel: Research in context
Systematic review
We searched PubMed for articles published in English, 
Spanish, and French between Jan 1, 2000, to Jan 1, 2014, that 
included the search terms “smoking” or “tobacco use” or 
“smokeless” or “cigarette” AND “maternal” or “pregnancy” or 
“pregnant women” in the title and were from low-income and 
middle-income countries. We identiﬁ ed only 16 primary 
research articles, of which three were based on national data.
Interpretation
Our study is the ﬁ rst study to report estimates of the 
prevalence of tobacco smoking and smokeless tobacco use in 
pregnant women in all 54 low-income and middle-income 
countries for which nationally representative data are 
available and comparable across countries. During 2001–12, 
about one in every 30 pregnant women from LMICs used 
tobacco, with wide variations in prevalence within and 
between world regions. Tobacco use in pregnant women in 
low- income and middle-income countries is low; however, in 
Turkey prevalence reaches as high as 15%.
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implemented. Urgent action is needed to prevent and 
manage tobacco use and second-hand smoke exposure 
in pregnancy to improve the health of women and 
children in LMICs at present.
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